In summary, our study has illuminated the relationship between TRIM64 and the NF-κB regulatory axis in atherosclerosis, suggesting that TRIM64 may serve as a potential target for future atherosclerosis therapy. This evidence concerns the gene TRIM64 and atherosclerosis.